|
Biotricity, Inc. (BTCY) DCF -Bewertung
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Biotricity, Inc. (BTCY) Bundle
Unabhängig davon, ob Sie ein Investor oder Analyst sind, ist dieser (BTCY) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Mit echten Daten von Biotricity, Inc., können Sie problemlos Prognosen anpassen und die Ergebnisse in Echtzeit beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4 | 3.4 | 7.7 | 9.6 | 12.1 | 19.6 | 32.0 | 52.0 | 84.7 | 137.9 |
| Revenue Growth, % | 0 | 138.75 | 126.02 | 26 | 25.15 | 62.79 | 62.79 | 62.79 | 62.79 | 62.79 |
| EBITDA | -10.9 | -13.4 | -18.0 | -15.4 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
| EBITDA, % | -771 | -394.47 | -235.55 | -159.81 | -73.75 | -94.75 | -94.75 | -94.75 | -94.75 | -94.75 |
| Depreciation | .1 | .3 | .1 | .3 | .0 | 1.0 | 1.6 | 2.6 | 4.3 | 7.0 |
| Depreciation, % | 10.49 | 10.26 | 0.89329 | 3.59 | 0.04934784 | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
| EBIT | -11.1 | -13.7 | -18.1 | -15.8 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
| EBIT, % | -781.49 | -404.72 | -236.45 | -163.4 | -73.8 | -94.76 | -94.76 | -94.76 | -94.76 | -94.76 |
| Total Cash | .9 | 2.2 | 12.1 | .6 | .8 | 9.6 | 15.6 | 25.4 | 41.4 | 67.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .5 | 1.5 | 2.0 | 1.2 | 1.8 | 5.2 | 8.5 | 13.9 | 22.6 | 36.7 |
| Account Receivables, % | 34.29 | 44.93 | 26.23 | 12.7 | 14.96 | 26.62 | 26.62 | 26.62 | 26.62 | 26.62 |
| Inventories | .1 | .3 | .8 | 2.3 | 1.9 | 2.6 | 4.2 | 6.8 | 11.0 | 17.9 |
| Inventories, % | 6.05 | 8.05 | 11.02 | 24.25 | 15.58 | 12.99 | 12.99 | 12.99 | 12.99 | 12.99 |
| Accounts Payable | 1.1 | 1.0 | 1.2 | 3.4 | 5.2 | 7.9 | 12.9 | 21.0 | 34.2 | 55.7 |
| Accounts Payable, % | 77.17 | 30.77 | 15.16 | 35.64 | 43.29 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | -.1 | -.1 |
| Capital Expenditure, % | 0 | 0 | -0.3891 | 0 | 0 | -0.07781949 | -0.07781949 | -0.07781949 | -0.07781949 | -0.07781949 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -11.1 | -13.7 | -18.1 | -15.8 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -10.4 | -14.6 | -19.0 | -13.8 | -7.2 | -19.0 | -28.6 | -46.6 | -75.8 | -123.4 |
| WACC, % | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 | 19.73 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -150.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -126 | |||||||||
| Terminal Value | -710 | |||||||||
| Present Terminal Value | -289 | |||||||||
| Enterprise Value | -439 | |||||||||
| Net Debt | 23 | |||||||||
| Equity Value | -462 | |||||||||
| Diluted Shares Outstanding, MM | 9 | |||||||||
| Equity Value Per Share | -51.35 |
What You Will Get
- Real BTCY Financial Data: Pre-filled with Biotricity’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Biotricity’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Data: Biotricity’s historical financial statements and detailed projections.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Monitor Biotricity’s intrinsic value calculations instantly.
- Visual Data Representation: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Biotricity, Inc. (BTCY) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the updated results, including Biotricity, Inc.'s (BTCY) intrinsic value.
- Step 5: Use the outputs to make informed investment decisions or create reports.
Why Choose Biotricity, Inc. (BTCY) Calculator?
- Save Time: Skip the hassle of building a financial model from the ground up – it's ready for immediate use.
- Enhance Accuracy: Dependable financial data and formulas minimize valuation errors.
- Fully Customizable: Adjust the model to align with your specific assumptions and forecasts.
- Easy to Understand: Intuitive charts and outputs simplify result analysis.
- Endorsed by Professionals: Crafted for experts who prioritize precision and user-friendliness.
Who Should Use Biotricity, Inc. (BTCY)?
- Healthcare Professionals: Understand the latest innovations in biometric monitoring and patient care.
- Researchers: Utilize Biotricity's technologies for studies in medical diagnostics and treatment efficacy.
- Investors: Evaluate market trends and performance metrics related to Biotricity, Inc. (BTCY) for informed investment decisions.
- Medical Device Analysts: Enhance your analysis with comprehensive data on Biotricity’s product offerings and market position.
- Entrepreneurs: Discover how Biotricity, Inc. (BTCY) is shaping the future of healthcare technology and explore potential business opportunities.
What the Template Contains
- Preloaded BTCY Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.